NDC - HCPCS Crosswalk

Effective January 1, 2019 through March 31, 2019

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
43066-018-01J9263Baxter Healthcare CorporationOxaliplatin0.5 MG201200200
45963-611-53J9263Actavis Pharma, Inc.Oxaliplatin0.5 MG11100100
45963-611-59J9263Actavis Pharma, Inc.Oxaliplatin0.5 MG11200200
45963-637-49J9263TEVA PHARMACEUTICALS USAOxaliplatin0.5 MG101100100
45963-638-58J9263TEVA PHARMACEUTICALS USAOxaliplatin0.5 MG201200200
47335-046-40J9263Sun Pharmaceutical Global Fze.Oxaliplatin0.5 MG11100100
47335-047-40J9263Sun Pharmaceutical Global Fze.Oxaliplatin0.5 MG11200200
47335-176-40J9263Sun Pharmaceutical Global Fze.Oxaliplatin0.5 MG11100100
47335-178-40J9263Sun Pharmaceutical Global Fze.Oxaliplatin0.5 MG11200200
47781-591-22J9263Alvogen, Inc.Oxaliplatin0.5 MG1010100100
47781-592-29J9263Alvogen, Inc.Oxaliplatin0.5 MG2010200200
51991-218-98J9263Breckenridge PharmaceuticalOxaliplatin0.5 MG1010100100
51991-219-98J9263Breckenridge PharmaceuticalOxaliplatin0.5 MG2010200200
51991-922-98J9263Breckenridge PharmaceuticalOxaliplatin0.5 MG1010100100
51991-923-98J9263Breckenridge PharmaceuticalOxaliplatin0.5 MG2010200200
61703-363-18J9263Pfizer Inc.Oxaliplatin0.5 MG101100100
61703-363-22J9263Pfizer Inc.Oxaliplatin0.5 MG201200200
63323-750-10J9263Fresenius Kabi USA LLCOxaliplatin0.5 MG101100100
63323-750-20J9263Fresenius Kabi USA LLCOxaliplatin0.5 MG201200200
67457-442-20J9263Mylan InstitutionalOxaliplatin0.5 MG201200200
67457-469-10J9263Mylan InstitutionalOxaliplatin0.5 MG101100100
68001-341-36J9263BLUEPOINT LABORATORIESOxaliplatin0.5 MG101100100
68001-341-37J9263BLUEPOINT LABORATORIESOxaliplatin0.5 MG201200200
70860-201-10J9263Athenex Pharmaceutical Division, LLC.Oxaliplatin0.5 MG1010100100
70860-201-20J9263Athenex Pharmaceutical Division, LLC.Oxaliplatin0.5 MG2010200200
68817-134-50J9264Celgene CorporationPaclitaxel protein bound1 MG501100100
0944-3810-01J9266Baxalta US Inc.Pegaspargase injection1 EA5111
0703-4764-01J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG513030
0703-4764-81J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG513030
0703-4766-01J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG16.71100100
0703-4766-81J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG16.71100100
0703-4767-01J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG251150150
0703-4768-01J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG501300300
0703-4768-81J9267Sicor Pharmaceuticals, Inc.Paclitaxel injection1 MG501300300
44567-505-01J9267WG Critical CarePaclitaxel injection1 MG16.71100100
44567-506-01J9267WG Critical CarePaclitaxel injection1 MG501300300
45963-613-53J9267Actavis Pharma, Inc.Paclitaxel injection1 MG16.71100100
45963-613-56J9267Actavis Pharma, Inc.Paclitaxel injection1 MG513030
45963-613-59J9267Actavis Pharma, Inc.Paclitaxel injection1 MG501300300
45963-613-83J9267ACTAVISPaclitaxel injection1 MG16.71100100
45963-613-86J9267TEVA PHARMACEUTICALS USAPaclitaxel injection1 MG513030
45963-613-89J9267TEVA PHARMACEUTICALS USAPaclitaxel injection1 MG501300300
47781-593-07J9267ALVOGENPaclitaxel injection1 MG513030
47781-594-07J9267ALVOGENPaclitaxel injection1 MG16.71100100
47781-595-07J9267ALVOGENPaclitaxel injection1 MG501300300
51991-936-98J9267Breckenridge PharmaceuticalPaclitaxel injection1 MG513030
51991-937-98J9267Breckenridge PharmaceuticalPaclitaxel injection1 MG16.71100100
51991-938-98J9267Breckenridge PharmaceuticalPaclitaxel injection1 MG501300300
61703-342-09J9267Pfizer Inc.Paclitaxel injection1 MG513030
61703-342-22J9267Pfizer Inc.Paclitaxel injection1 MG16.71100100
61703-342-50J9267Pfizer Inc.Paclitaxel injection1 MG501300300
63323-763-05J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG513030
63323-763-06J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG513030
63323-763-16J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG16.71100100
63323-763-17J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG16.71100100
63323-763-50J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG501300300
63323-763-52J9267Fresenius Kabi USA LLCPaclitaxel injection1 MG501300300
67457-434-51J9267Mylan InstitutionalPaclitaxel injection1 MG501300300
67457-449-17J9267Mylan InstitutionalPaclitaxel injection1 MG16.71100100
67457-471-52J9267Mylan InstitutionalPaclitaxel injection1 MG513030
Page 62